CoCo-PCOS - Comprehensive Health Effects of Combined Contraceptives: a 6-month randomized, controlled, open-label trial of E4+DRSP, EE20µg+DRSP, and DRSP-only in women with PCOS

Status

Not yet recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-523358-15-00

Enrollment

156

Registered

2026-04-20

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception

Brief summary

6-month use of study preparation, endpoint visit

Interventions

DRUGDrovelis 3 mg/14.2 mg film-coated tablets

DRUGSlinda 4 mg kalvopäällysteinen tabletti

DRUGDaylette 0

DRUG02 mg / 3 mg tabletti

DRUGkalvopäällysteinen

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Design outcomes

Primary

Measure	Time frame
6-month use of study preparation, endpoint visit	—

Outcome results

None listed

Source: EU CTIS · Data processed: Apr 21, 2026